The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...
A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...
8h
Investor's Business Daily on MSNDow Jones Futures Fall, Trump Imposes New Tariffs; Nvidia Faces This Critical Test At Key LevelNvidia stock rallied to a critical level Monday, with Fed Chairman Jerome Powell set to testify in front of Congress.
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
A new report into the state of inflammatory bowel disease in Australia has revealed rates of the life long disease in the ...
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...
The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...
This ‘below the button’ disease is hitting too many Australians. Why is no one talking about it?
While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results